Brand Post

FractIt, a pioneering blockchain platform, has successfully completed its Pilot program, tokenizing a prestigious 3BHK condo in Shimla’s Cliffton Valley…

NASSAU, The Bahamas, June 01, 2024 (GLOBE NEWSWIRE) — OKX, a leading crypto exchange by trading volume and a leading…

LOS ANGELES, June 1, 2024 /PRNewswire/ — Vincent Todd is pleased to announce the introduction of generative agriculture firm Todd…

An Innovative Line of Professional Cosmeceutical Formulas Designed To Help People “Rewind Time” on their Skin BEVERLY HILLS, Calif., June…

Collaboration advances Cancer Moonshot call to empower patients, reduce duplication CHICAGO, June 1, 2024 /PRNewswire/ — The American Cancer Society (ACS)…

Newly Launched Technology Will Be on Display at ASSFN in Nashville from June 1 – 4 ClearPoint Neuro Announces Full…

Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, cell and gene therapy, clinical trials, commercialization & HEOR,…

Zanidatamab demonstrated a median overall survival (OS) of 15.5 months in patients with centrally confirmed immunohistochemistry (IHC) 2+ or 3+ and…

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to…

Data demonstrated promising monotherapy activity with olomorasib across a range of KRAS G12C-mutant solid tumors, including non-small cell lung cancer,…

26% reduction in risk of death (HR=0.74) and 28% risk reduction in progression or death (HR=0.72) in previously-treated patients administered…

Poster presentation features the interim data from an ongoing Phase 1b clinical trial of TU2218 plus Keytruda combination therapy in patients…

Los Angeles, CA, USA, June 01, 2024 (GLOBE NEWSWIRE) — OkayCoin, a pioneering force in the cryptocurrency staking sphere, today announced a…

KERRVILLE, Texas, June 1, 2024 /PRNewswire/ — James Avery Artisan Jewelry, a family-owned jewelry retailer based in Texas, is excited to…

BOSTON, June 1, 2024 /PRNewswire/ — Immunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, ImmuAlpaca®…